HFE genotypes, haemochromatosis diagnosis and clinical outcomes at age 80 years: a prospective cohort study in the UK Biobank
Objectives HFE haemochromatosis genetic variants have an uncertain clinical penetrance, especially to older ages and in undiagnosed groups. We estimated p.C282Y and p.H63D variant cumulative incidence of multiple clinical outcomes in a large community cohort.Design Prospective cohort study.Setting 2...
Saved in:
| Main Authors: | Luke C Pilling, David Melzer, Janice L Atkins, Mitchell R Lucas, Jeremy D Shearman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-03-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/14/3/e081926.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preventing organ damage by genetic testing for hereditary haemochromatosis
by: M.J. Kotze, et al.
Published: (2005-03-01) -
Primary Terminal Haemochromatosis in a 50 Year-Old Patient
by: M. I. Gonik, et al.
Published: (2021-04-01) -
Iron overload phenotypes and HFE genotypes in white hemochromatosis and iron overload screening study participants without HFE p.C282Y/p.C282Y.
by: James C Barton, et al.
Published: (2022-01-01) -
Understanding the causes and consequences of low statin adherence: evidence from UK Biobank primary care data
by: Deniz Türkmen, et al.
Published: (2025-07-01) -
APOE Genotype and Statin Response: Evidence From the UK Biobank and All of Us Program
by: Innocent G. Asiimwe, et al.
Published: (2025-08-01)